Genomic Diversity of a Globally Used, Live Attenuated Mycoplasma Vaccine
暂无分享,去创建一个
A. Noormohammadi | M. Marenda | S. Catania | M. Gyuranecz | Z. Kreizinger | C. Morrow | D. Andrews | A. Feberwee | Pollob Shil | M. Bottinelli | G. Underwood | Dorottya Földi | O. Olaogun | Sara M. Klose | Jillian F. Disint | Arianna Dall'Ora | Marleen van der Most
[1] M. Zubair,et al. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) moonlights as an adhesin in Mycoplasma hyorhinis adhesion to epithelial cells as well as a plasminogen receptor mediating extracellular matrix degradation , 2021, Veterinary Research.
[2] S. Khurana,et al. Insights on Mycoplasma gallisepticum and Mycoplasma synoviae infection in poultry: a systematic review , 2021, Animal biotechnology.
[3] D. Tull,et al. A Mycoplasma gallisepticum Glycerol ABC Transporter Involved in Pathogenicity , 2021, Applied and Environmental Microbiology.
[4] A. Noormohammadi,et al. Preliminary comparative analysis of the genomes of selected field reisolates of the Mycoplasma synoviae vaccine strain MS-H reveals both stable and unstable mutations after passage in vivo , 2020, BMC Genomics.
[5] K. Bányai,et al. Mutations potentially associated with decreased susceptibility to fluoroquinolones, macrolides and lincomycin in Mycoplasma synoviae. , 2020, Veterinary microbiology.
[6] G. Browning,et al. Comparative genomic analyses of Mycoplasma synoviae vaccine strain MS-H and its wild-type parent strain 86079/7NS: implications for the identification of virulence factors and applications in diagnosis of M. synoviae , 2019, Avian pathology : journal of the W.V.P.A.
[7] C. Lartigue,et al. Attenuation of a Pathogenic Mycoplasma Strain by Modification of the obg Gene by Using Synthetic Biology Approaches , 2019, mSphere.
[8] A. Noormohammadi,et al. Mutation of oppF gene in the Mycoplasma synoviae MS-H vaccine strain and its implication for differential serological responses to vaccination versus field challenge. , 2019, Veterinary microbiology.
[9] R. Dumke,et al. Organization of multi-binding to host proteins: The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) of Mycoplasma pneumoniae. , 2019, Microbiological research.
[10] K. Bányai,et al. Genotyping Mycoplasma synoviae: Development of a multi-locus variable number of tandem-repeats analysis and comparison with current molecular typing methods. , 2018, Veterinary microbiology.
[11] Min Hu,et al. Identification of erythrocyte membrane proteins interacting with Mycoplasma suis GAPDH and OSGEP. , 2018, Research in veterinary science.
[12] N. Thomson,et al. Genomic evidence that the live Chlamydia abortus vaccine strain 1B is not attenuated and has the potential to cause disease , 2018, Vaccine.
[13] Torsten Schwede,et al. SWISS-MODEL: homology modelling of protein structures and complexes , 2018, Nucleic Acids Res..
[14] Yi-ning Wang,et al. Unique features of nucleotide and codon usage patterns in mycoplasmas revealed by information entropy , 2018, Biosyst..
[15] M. McConville,et al. Comparative Metabolomics of Mycoplasma bovis and Mycoplasma gallisepticum Reveals Fundamental Differences in Active Metabolic Pathways and Suggests Novel Gene Annotations , 2017, mSystems.
[16] A. Kanci,et al. Identification of a new genetic marker in Mycoplasma synoviae vaccine strain MS-H and development of a strategy using polymerase chain reaction and high-resolution melting curve analysis for differentiating MS-H from field strains. , 2017, Veterinary microbiology.
[17] Tom L. Blundell,et al. SDM: a server for predicting effects of mutations on protein stability , 2017, Nucleic Acids Res..
[18] Melanie Pfeiffer,et al. Network of Surface-Displayed Glycolytic Enzymes in Mycoplasma pneumoniae and Their Interactions with Human Plasminogen , 2015, Infection and Immunity.
[19] Jian-hua Zhou,et al. The Effect of Multiple Evolutionary Selections on Synonymous Codon Usage of Genes in the Mycoplasma bovis Genome , 2014, PloS one.
[20] N. Verstraeten,et al. Bacterial Obg proteins: GTPases at the nexus of protein and DNA synthesis , 2014, Critical reviews in microbiology.
[21] P. Markham,et al. High-Resolution Melting-Curve Analysis of obg Gene to Differentiate the Temperature-Sensitive Mycoplasma synoviae Vaccine Strain MS-H from Non-Temperature-Sensitive Strains , 2014, PloS one.
[22] P. Markham,et al. Mutations in GTP Binding Protein Obg of Mycoplasma synoviae Vaccine Strain MS-H: Implications in Temperature-Sensitivity Phenotype , 2013, PloS one.
[23] S. Catania,et al. Molecular Characterization of Acquired Enrofloxacin Resistance in Mycoplasma synoviae Field Isolates , 2013, Antimicrobial Agents and Chemotherapy.
[24] P. Markham,et al. Combination of differential growth at two different temperatures with a quantitative real-time polymerase chain reaction to determine temperature-sensitive phenotype of Mycoplasma synoviae , 2013, Avian pathology : journal of the W.V.P.A.
[25] R. Dumke,et al. Role of Mycoplasma pneumoniae glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in mediating interactions with the human extracellular matrix. , 2011, Microbiology.
[26] P. Markham,et al. GapA+ Mycoplasma gallisepticum ts-11 has improved vaccine characteristics. , 2011, Microbiology.
[27] P. Markham,et al. Developing attenuated vaccines to control mycoplasmoses , 2011 .
[28] S. Djordjevic,et al. Identification of Lipoprotein MslA as a Neoteric Virulence Factor of Mycoplasma gallisepticum , 2010, Infection and Immunity.
[29] W. Landman,et al. Induction of eggshell apex abnormalities by Mycoplasma synoviae: field and experimental studies , 2009, Avian pathology : journal of the W.V.P.A.
[30] W. Haldenwang,et al. The Growth-Promoting and Stress Response Activities of the Bacillus subtilis GTP Binding Protein Obg Are Separable by Mutation , 2008, Journal of bacteriology.
[31] Sen-Lin Tang,et al. Differential expression of lipoprotein genes in Mycoplasma pneumoniae after contact with human lung epithelial cells, and under oxidative and acidic stress , 2008, BMC Microbiology.
[32] W. Landman,et al. In vitro antibiotic susceptibility of Dutch Mycoplasma synoviae field isolates originating from joint lesions and the respiratory tract of commercial poultry , 2008, Avian pathology : journal of the W.V.P.A.
[33] P. Dovc,et al. Identification of major immunogenic proteins of Mycoplasma synoviae isolates. , 2008, Veterinary microbiology.
[34] R. Gasser,et al. Classification of Mycoplasma synoviae strains using single-strand conformation polymorphism and high-resolution melting-curve analysis of the vlhA gene single-copy region. , 2007, Microbiology.
[35] K. Cecchini,et al. Transcriptional Responses of Mycoplasma gallisepticum Strain R in Association with Eukaryotic Cells , 2007, Journal of bacteriology.
[36] J. Meens,et al. Identification and immunological characterization of conserved Mycoplasma hyopneumoniae lipoproteins Mhp378 and Mhp651. , 2006, Veterinary microbiology.
[37] A. Noormohammadi,et al. Duration of immunity with Mycoplasma synoviae: comparison of the live attenuated vaccine MS-H (Vaxsafe MS) with its wild-type parent strain, 86079/7NS. , 2006, Avian diseases.
[38] V. Pereira,et al. Avian mycoplasmosis update , 2005 .
[39] R. Hoffmann,et al. P80, the HinT interacting membrane protein, is a secreted antigen of Mycoplasma hominis , 2004, BMC Microbiology.
[40] C. Gyles,et al. Pathogenesis of bacterial infections in animals , 2004 .
[41] V. Govorun,et al. Mechanisms of Genetic Instability in Mollicutes (Mycoplasmas) , 2001, Russian Journal of Genetics.
[42] B. Roe,et al. Gene content and organization of an 85-kb DNA segment from the genome of the phytopathogenic mollicute Spiroplasma kunkelii , 2003, Molecular Genetics and Genomics.
[43] J. Baseman,et al. Surface localized glyceraldehyde‐3‐phosphate dehydrogenase of Mycoplasma genitalium binds mucin , 2003, Molecular microbiology.
[44] C. Lima,et al. Structural and biochemical analysis of the Obg GTP binding protein. , 2002, Structure.
[45] I. Kempf,et al. In vitro development of resistance to enrofloxacin, erythromycin, tylosin, tiamulin and oxytetracycline in Mycoplasma gallisepticum, Mycoplasma iowae and Mycoplasma synoviae. , 2002, Veterinary microbiology.
[46] S. Moriya,et al. Deficiency of essential GTP‐binding protein ObgE in Escherichia coli inhibits chromosome partition , 2001, Molecular microbiology.
[47] S. Uzzau,et al. Sequence, cloning, expression and characterisation of the 81-kDa surface membrane protein (P80) of Mycoplasma agalactiae. , 2001, FEMS microbiology letters.
[48] K. Wise,et al. Coupled Phase-Variable Expression and Epitope Masking of Selective Surface Lipoproteins Increase Surface Phenotypic Diversity in Mycoplasma hominis , 2001, Infection and Immunity.
[49] R. Karron,et al. Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy. , 2000, The Journal of infectious diseases.
[50] J. Maddock,et al. The N‐terminal domain of the Caulobacter crescentus CgtA protein does not function as a guanine nucleotide exchange factor , 2000, FEBS letters.
[51] P. Markham,et al. A novel mechanism for control of antigenic variation in the haemagglutinin gene family of Mycoplasma synoviae , 2000, Molecular microbiology.
[52] P. Scott,et al. Field evaluation of the safety and efficacy of a temperature-sensitive Mycoplasma synoviae live vaccine. , 1998, Avian diseases.
[53] C. Morrow,et al. Safety of a temperature-sensitive clone of Mycoplasma synoviae as a live vaccine. , 1998, Avian diseases.
[54] C. Morrow,et al. Production of temperature-sensitive clones of Mycoplasma synoviae for evaluation as live vaccines. , 1998, Avian diseases.
[55] M. Stegemann,et al. Comparative susceptibilities of various animal-pathogenic mycoplasmas to fluoroquinolones , 1997, Antimicrobial agents and chemotherapy.
[56] K. Wise,et al. Elongated versions of Vlp surface lipoproteins protect Mycoplasma hyorhinis escape variants from growth-inhibiting host antibodies , 1997, Infection and immunity.
[57] K. Wise,et al. Antigenic topology of the P29 surface lipoprotein of Mycoplasma fermentans: differential display of epitopes results in high-frequency phase variation , 1996, Infection and immunity.
[58] J. Hoch,et al. Effects on Bacillus subtilis of a conditional lethal mutation in the essential GTP-binding protein Obg , 1994, Journal of bacteriology.
[59] K. Whithear,et al. Safety of temperature sensitive mutant Mycoplasma gallisepticum vaccine. , 1990, Australian veterinary journal.
[60] G. Barroso,et al. Lethal and mutation frequency responses of Spiroplasma citri cells to UV irradiation. , 1989, Mutation research.
[61] T E Carpenter,et al. Economic impact of Mycoplasma gallisepticum and M. synoviae in commercial layer flocks. , 1987, Avian diseases.
[62] T. Farver,et al. Immunization of chickens with temperature-sensitive mutants of Mycoplasma gallisepticum. , 1983, Avian diseases.
[63] D. C. Krause,et al. Identification of Mycoplasma pneumoniae proteins associated with hemadsorption and virulence , 1982, Infection and immunity.
[64] B. Cox,et al. Reversion analysis of [psi-] mutations in Saccharomyces cerevisiae. , 1981, Genetical research.
[65] L. Babiuk,et al. Reactivation of temperature-sensitive and non-temperature-sensitive infectious bovine rhinotracheitis vaccine virus with dexamethasone , 1980, Infection and immunity.
[66] D. P. Anderson,et al. Field studies with Mycoplasma synoviae. , 1973, Avian diseases.
[67] R. Hanson,et al. A medium for the isolation of avian mycoplasmas. , 1968, American journal of veterinary research.
[68] D. A. Munro,et al. Studies of infectious synovitis in chickens. , 1956, American journal of veterinary research.